Canine antimicrobial peptides are effective against resistant bacteria and yeasts

Veterinary Dermatology

Volumn 25, Issue 1, 2014, Pages

  Santoro, Domenico ^a   Maddox, Carol W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; CANIS FAMILIARIS; ESCHERICHIA COLI; MALASSEZIA PACHYDERMATIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

ANTIMICROBIAL CATIONIC PEPTIDE;

ANIMAL; ANTIBIOTIC RESISTANCE; ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIUM; DOG; DRUG EFFECT; METABOLISM; MICROBIAL SENSITIVITY TEST; YEAST;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; DOGS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; MICROBIAL SENSITIVITY TESTS; YEASTS;

EID: 84892893902     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12091     Document Type: Article

References (15)

1. DeBoer DJ, Marsella R. The ACVD task force on canine atopic dermatitis (XII): the relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis. Vet Immunol Immunopathol 2001; 81: 239-249.
2. Kedzierska A, Kapińska-Mrowiecka M, Czubak-Macugowska M et al. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Br J Dermatol 2008; 159: 1290-1299.
3. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511.
4. Braff MH, Bardan A, Nizet V et al. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125: 9-13.
5. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993; 61: 2978-2984.
6. Leonard BC, Affolter VK, Bevins CL. Antimicrobial peptides: agents of border protection for companion animals. Vet Dermatol 2012; 23: 177-e36.
7. Santoro D, Bunick D, Graves TK et al. Expression and distribution of antimicrobial peptides in the skin of healthy beagles. Vet Dermatol 2011; 22: 61-67.
8. Sang Y, Ortega T, Blecha F et al. Molecular cloning and characterization of three β-defensins from canine testes. Infect Immun 2005; 73: 2611-2620.
9. Erles K, Brownlie J. Expression of β-defensins in the canine respiratory tract and antimicrobial activity against Bordetella bronchiseptica. Vet Immunol Immunopathol 2010; 135: 12-19.
10. Leonard BC, Marks SL, Outerbridge CA et al. Activity, expression and genetic variation of canine β-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs. J Innate Immun 2012; 4: 248-259.
11. Sang Y, Teresa Ortega M, Rune K et al. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol 2007; 31: 1278-1296.
12. Fazakerley J, Crossley J, McEwan N et al. In vitro antimicrobial efficacy of β-defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin. Vet Dermatol 2010; 21: 463-468.
13. Fritz P, Beck-Jendroschek V, Brasch J. Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin. Med Mycol 2012; 50: 579-584.
14. Watts JL, Shryock TR, Apley M et al. Performance standards for antimicrobial disk and dilution susceptibility tests of bacteria isolated from animals; approved standard - third edition. CLSI Bulletin 2008; 28: 23-37.
15. Rex JH, Alexander BD, Andes D et al. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard - third edition. CLSI Bulletin 2008; 28: 6-11.